Johnson, Braden, Tony Pham, Kate Young, Leonidas Bantis, Weijing Sun, and Anup Kasi. 2022. “Epidermal Growth Factor Receptor Inhibitor Treatment Timing Does Not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study: EGFR Inhibitor Treatment Line Outcomes”. Kansas Journal of Medicine 15 (2): 273-77. https://doi.org/10.17161/kjm.vol15.15975.